Literature DB >> 27538667

The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease.

Sung Hoon Kang1, Hye Mi Lee1, Woo-Keun Seo1, Ji Hyun Kim1, Seong-Beom Koh2.   

Abstract

BACKGROUND: Olfactory dysfunction and REM sleep behavior disorder (RBD) are recognized as pre-motor symptoms of Parkinson's disease (PD). Cognitive dysfunction is observed at a high rate even in the early stages of PD as an important non-motor symptom. PD has been classified in different subtypes and it is unknown if olfactory dysfunction and RBD occur more often in one particular subtype. We investigated the relationship between olfactory impairment, RBD, initial cognitive performance and motor phenotype in PD.
METHOD: Nighty-eight patients with drug-naïve idiopathic PD who visited the Movement Disorders Unit of Korea University Guro Hospital, Seoul, Korea from March 2012 to February 2014 were retrospectively included. Patients were divided into tremor-dominant-type and akinetic-rigid-type PD subgroups using part III of the Unified Parkinson's Disease Rating Scale. Olfaction was assessed by the Cross Cultural Smell Identification Test. RBD was screened using screening questionnaires. Initial cognitive function was assessed with Mini-Mental State Examination. RESULT: The PD-normosmia group had higher MMSE scores (p=0.008). PD patients who have both RBD and olfactory dysfunction had lower MMSE scores (p=0.013). Presence of both RBD and hyposmia in PD patients was more strongly correlated with poor cognitive dysfunction. PD patients with RBD and/or hyposmia primarily exhibited the akinetic-rigidity phenotype.
CONCLUSION: Olfactory dysfunction and RBD differed according to the motor phenotypes of PD. This suggests that olfactory dysfunction and RBD might relate to prognosis in patients with PD. Patients who have both hyposmia and RBD were more likely to exhibit cognitive dysfunction.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive dysfunction; Hyposmia; Motor phenotype; Parkinson's disease; REM sleep behavior disorder

Mesh:

Year:  2016        PMID: 27538667     DOI: 10.1016/j.jns.2016.07.057

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

Review 1.  Premotor Diagnosis of Parkinson's Disease.

Authors:  Heinz Reichmann
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

Review 2.  Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.

Authors:  Michelle E Fullard; James F Morley; John E Duda
Journal:  Neurosci Bull       Date:  2017-08-22       Impact factor: 5.203

Review 3.  Advances in markers of prodromal Parkinson disease.

Authors:  Ronald B Postuma; Daniela Berg
Journal:  Nat Rev Neurol       Date:  2016-10-27       Impact factor: 42.937

4.  Association Between Olfactory Impairment and Disease Severity and Duration in Parkinson's Disease.

Authors:  Shoichi Sasaki; Yoshiharu Horie
Journal:  Mov Disord Clin Pract       Date:  2020-08-28

Review 5.  Sleep Disorders and Cognitive Dysfunctions in Parkinson's Disease: A Meta-Analytic Study.

Authors:  Gianpaolo Maggi; Luigi Trojano; Paolo Barone; Gabriella Santangelo
Journal:  Neuropsychol Rev       Date:  2021-03-29       Impact factor: 7.444

Review 6.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

7.  Olfactory Testing in Parkinson Disease and REM Behavior Disorder: A Machine Learning Approach.

Authors:  Christine Lo; Siddharth Arora; Yoav Ben-Shlomo; Thomas R Barber; Michael Lawton; Johannes C Klein; Sofia Kanavou; Annette Janzen; Elisabeth Sittig; Wolfgang H Oertel; Donald G Grosset; Michele T Hu
Journal:  Neurology       Date:  2021-02-24       Impact factor: 9.910

8.  Associations Between Olfactory Impairment and Cognitive Functions in Patients with Parkinson Disease.

Authors:  Nilüfer Büyükkoyuncu Pekel; Demet Yildiz; İbrahim Taymur; Ersin Budak; Suay Özmen; Çağla Çapkur; Meral Seferoğlu; Aygül Güneş; Deniz Siğirli
Journal:  Noro Psikiyatr Ars       Date:  2019-02-05       Impact factor: 1.339

9.  Validation of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Sleep.

Authors:  Young Hee Sung; Hee Jin Kim; Seong Beom Koh; Joong Seok Kim; Sang Jin Kim; Sang Myung Cheon; Jin Whan Cho; Yoon Joong Kim; Hyeo Il Ma; Mee Young Park; Jong Sam Baik; Phil Hyu Lee; Sun Ju Chung; Jong Min Kim; In Uk Song; Han Joon Kim; Ji Young Kim; Do Young Kwon; Jae Hyeok Lee; Jee Young Lee; Ji Seon Kim; Ji Young Yun; Jin Yong Hong; Mi Jung Kim; Jinyoung Youn; Ji Sun Kim; Eung Seok Oh; Hui Jun Yang; Won Tae Yoon; Sooyeoun You; Kyum Yil Kwon; Hyung Eun Park; Su Yun Lee; Younsoo Kim; Hee Tae Kim; Tae Beom Ahn
Journal:  J Korean Med Sci       Date:  2018-01-08       Impact factor: 2.153

10.  Hyposmia Is Associated with RBD for PD Patients with Variants of SNCA.

Authors:  Yuanyuan Li; Wenyan Kang; Linyuan Zhang; Liche Zhou; Mengyue Niu; Jun Liu
Journal:  Front Aging Neurosci       Date:  2017-09-20       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.